A detailed history of Fairfield, Bush & Co. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Fairfield, Bush & Co. holds 2,930 shares of LNTH stock, worth $320,366. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,930
Holding current value
$320,366
% of portfolio
0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$58.87 - $83.05 $172,489 - $243,336
2,930 New
2,930 $235 Million
Q4 2023

Feb 13, 2024

BUY
$55.6 - $77.89 $96,188 - $134,749
1,730 New
1,730 $107 Million
Q2 2023

Aug 15, 2023

BUY
$82.41 - $99.65 $142,569 - $172,394
1,730 New
1,730 $145 Million
Q2 2022

Aug 09, 2022

SELL
$55.54 - $72.65 $14,995 - $19,615
-270 Reduced 8.44%
2,930 $193,000
Q1 2022

May 06, 2022

BUY
$24.28 - $56.64 $77,696 - $181,248
3,200 New
3,200 $177,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.52B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Fairfield, Bush & Co. Portfolio

Follow Fairfield, Bush & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.